Combined treatments in hepatocellular carcinoma: Time to put them in the guidelines?

Table 1 Morbidity, mortality, recurrence and survival after hepatic resection plus intraoperative ablation

Ref.	Patients, n (%)	MO, n (%)	Mo, n (%)	Recurrence	Survival rates (1 yr/3 yr/5 yr)
Qiu et al[6], 2014	112	2	22.3	72.3%	67.5%/32.5%/12.5%
Hou et al[23], 2016	51	0	70.6	54.9%	88.2%/66.7%/52.9%
Zhang et al[24], 2014	114	0.9	-	-	34.4%/70.7%/40.7%
Huang et al[25], 2020	51	-	-	-	86.3%/66.6%/34.2%

MO: Mortality; Mo: Morbidity.